Pharma / Biotech
Mpox, Explained: Key Details On Latest Virus Outbreak
Forbes August 16, 2024
5 takeaways from first Medicare drug price negotiations
Hill August 16, 2024
Investors shrug off drug price talks' effects
AXIOS August 16, 2024
Mpox Vaccine Maker’s Shares Continue Rising As Concern Over Virus Outbreak Grows
Forbes August 16, 2024
PINNACLE AI model advances protein analysis in real-world contexts
News-Medical.Net August 16, 2024
Pfizer and BioNTech’s Covid-19/flu combination vaccine falters in Phase III readout
Clinical Trials Arena August 16, 2024
New deals will cut medicare costs for expensive drugs
Medical Xpress August 15, 2024
Medicare reveals results of drug price negotiations
BioPharma Dive August 15, 2024
Mpox vaccine maker ready to produce 10 million doses
Medical Xpress August 15, 2024
Mark Cuban to publish Cost Plus Drug contracts
Becker's Healthcare August 15, 2024
CMS' negotiated drug prices: 12 notes
Becker's Healthcare August 15, 2024
Weight loss drugs could cost Medicare $6B a year: Study
Becker's Healthcare August 15, 2024
UN talks aim to turn DNA data into assets
AXIOS August 15, 2024
Higher Drug Costs, Less Choice: How PBMs Affect Everyday Americans’ Healthcare
Forbes August 15, 2024
Mark Cuban wants to keep shaking up healthcare. Here's Cost Plus Drug's next move
Fierce Healthcare August 15, 2024
Pharma Pulse 8/15/24: Complying with the DSCSA, Justice Department Changing Tactics on...
Pharmaceutical Executive August 15, 2024
Incyte builds out its arsenal of post-transplant drugs
BioPharma Dive August 15, 2024
A Roadmap to Pharma Resilience
Pharmaceutical Executive August 15, 2024
Vaccine Maker Shares Soar After WHO Declares Health Emergency Over Africa Mpox Outbreak
Forbes August 15, 2024
AstraZeneca said to be wavering on £450m UK vaccine plant
pharmaphorum August 15, 2024
Cancer-focused Actuate is latest biotech on Nasdaq after $22.4M IPO
Fierce Biotech August 15, 2024
Big Pharma push back on first Medicare drug price cuts
Medical Xpress August 15, 2024
Ozempic Is Raising Your Health Premiums Even If You’re Not Taking It
Forbes August 15, 2024